Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone (original) (raw)
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime Subscribe now
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
References
- Alleva, P. M.: Primi risultati sul trattamento di 60 casi di malattie mentali con un nuovo neurolettico, l'haloperidol (R 1625). Freniatria 84, 1 (1960).
Google Scholar - Broadhurst, P. L.: Determinants of emotionality in the rat. II. Antecedent factors. Brit. J. Psychol. 49, 12–20 (1958).
Google Scholar - Delay, J., P. Pichot, T. Lempérière, B. Elissalde et F. Peigne: Un neuroleptique majeur non phénothiazinique et non réserpinique, l'haloperidol, dans les traitement des psychoses. Ann. méd.-psychol. 118, 145–152 (1960).
Google Scholar - Divry, P., J. Bobon et J. Collard: Le ≪R 1625≫: nouvelle thérapeutique symptomatique de l'agitation psychomotrice. Acta neurol. belg. 58, 878–888 (1958).
Google Scholar - Divry, P., J. Bobon, J. Collard, A. Pinchard et E. Nols: Etude et expérimentation cliniques du R 1625 ou haloperidol, nouveau neuroleptique et ≪neurodysleptique≫. Acta neurol. belg. 59, 337–366 (1959).
Google Scholar - Flegel, H., A. Rasper et H. Lauber: Etude clinique du R 1625 ou haloperidol. Communication au Congrès de Psychiatrie et de Neurologie de Langue Française, LVII. Session, Tours (France) 8–13 juin 1959.
- Jacobs, R.: Klinische ervaring met R 1625 (Haloperidol). Psychiatrie en Verpleging No 1, p. 8–18 (1959); No 211, p. 20–32 (1959); No 2, p. 16–23 (1960).
- Janssen, P. A. J., A. H. Jageneau, J. Huygens, P. J. A. Demoen, C. van de Westeringh and M. Wouters: Synthetic anti-diarrheal agents. Part I. Synthesis and pharmacological properties of R 1132 and related compounds. J. Med. Pharm. Chem. 1, 299–308 (1959a).
Google Scholar - Janssen, P.A. J., and C. J. E. Niemegeers: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part II. Inhibition of apomorphine-vomiting in dogs. Arzneimittel-Forsch. 9, 765–767 (1959b).
Google Scholar - Janssen, P. A. J., C. E. J. Niemegeers and K. H. L. Schellekens: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part III. Duration of antiemetic action and oral effectiveness of haloperidol (R 1625) and of chlorpromazine in dogs. Arzneimittel-Forsch. 1960a (in the press).
- Janssen, P. A. J., C. van de Westeringh, A. H. M. Jageneau, P. J. A. Demoen, B. K. F. Hermans, G. H. P. van Daele, K. H. L. Schellekens, C. A. M. van der Eycken and C. J. E. Niemegeers: Chemistry and pharmacology of CNS depressants related to 4-(4-hydroxy-4-penylpiperidino) butyrophenone. Part I. Synthesis and screening data in mice. J. Med. Pharm. Chem. 1, 281–297 (1959c).
Google Scholar - Kristjansen, P.: Expérimentation clinique du R 1625. Congrès de Psychiatrie et de Neurologie de Langue Française, LVII. Session, Tours (France) 8–13 juin 1959.
- Paquay, J., F. Arnould et P. Burton: Etude clinique de l7action du R 1625 a doses modérées en psychiatrie. Acta neurol belg. 59, 882–891 (1959).
Google Scholar - Paquay, J., F. Arnould et P. Burton: Etude de l'action du R 1625 (Halopéridol) sur 62 cas de schizophrénie. Congrès de Psychiatrie et de Neurologie de Langue Française, LVII. Session, Tours (France) 8–13 juin 1959.
- Ryall, R. W.: Effect of drugs on emotional behaviour in rats. Nature (Lond.) 182, 1606–1607 (1958).
Google Scholar - Siegel, S.: Nonparametric statistics for the behavioral sciences. McGraw-Hill series in psychology, 1956, p. 47 and 127.